Transplant Rejection
Transplant rejection occurs when a recipient's immune system identifies a transplanted organ or tissue as foreign and attacks it. This happens because the immune system, which defends the body against infections, recognizes differences in proteins (antigens) between the donor and the recipient. There are three main types: acute, chronic, and hyperacute rejection, each varying in timing and severity. To prevent rejection, patients take immunosuppressive drugs that weaken their immune response, helping the body accept the new organ. Monitoring and management are crucial for the long-term success of the transplant.
Additional Insights
-
Transplant rejection occurs when a recipient's immune system recognizes a transplanted organ or tissue as foreign and attacks it. This response happens because the body views the new tissue as a threat, similar to how it would respond to harmful bacteria or viruses. There are different types of rejection, including acute and chronic, varying in timing and severity. To prevent rejection, patients often take immunosuppressive medications that help their immune system accept the transplant. However, these medications can increase the risk of infections and other complications, which is a key consideration in post-transplant care.
-
Transplant rejection occurs when a patient’s immune system identifies a transplanted organ or tissue as foreign and attacks it. This happens because the immune system is designed to protect the body from infections and recognizes the new organ as a potential threat. There are different types of rejection, including acute and chronic, and symptoms can vary. To minimize the risk of rejection, transplant recipients must take immunosuppressive medications to weaken their immune response. Monitoring and managing rejection are critical for the success of the transplant and the health of the recipient.